A Study to Examine the Potential Effect of Rifampin on the Pharmacokinetics of Bosutinib When Administered Concomitantly to Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 May 2009
At a glance
- Drugs Bosutinib; Rifampicin
- Indications Acute lymphoblastic leukaemia; Breast cancer; Chronic myeloid leukaemia; Tuberculosis
- Focus Pharmacokinetics
- Sponsors Wyeth
- 01 May 2009 Actual initiation date (Jul 2008) added as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 23 Aug 2008 New trial record.